Robert Gross
Concepts (358)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Calcium Channels | 13 | 1988 | 52 |
Why?
| Disclosure | 2 | 2010 | 19 |
Why?
| Conflict of Interest | 2 | 2010 | 21 |
Why?
| Editorial Policies | 2 | 2009 | 9 |
Why?
| Neurology | 3 | 2008 | 28 |
Why?
| Neurons | 15 | 1986 | 195 |
Why?
| Ganglia, Spinal | 11 | 1987 | 21 |
Why?
| Anticonvulsants | 5 | 1997 | 61 |
Why?
| Calcium | 14 | 1977 | 208 |
Why?
| Epilepsy | 6 | 1992 | 49 |
Why?
| Neurons, Afferent | 7 | 1989 | 48 |
Why?
| Authorship | 2 | 2010 | 9 |
Why?
| Seizures | 6 | 1979 | 79 |
Why?
| Dentate Gyrus | 3 | 2002 | 20 |
Why?
| Periodicals as Topic | 2 | 2010 | 41 |
Why?
| Nodose Ganglion | 9 | 1990 | 1 |
Why?
| Publication Bias | 1 | 2011 | 8 |
Why?
| Portraits as Topic | 1 | 2010 | 2 |
Why?
| Equipment and Supplies | 1 | 2010 | 7 |
Why?
| Photography | 1 | 2010 | 27 |
Why?
| Missions and Missionaries | 1 | 2010 | 1 |
Why?
| Drug Industry | 1 | 2010 | 18 |
Why?
| Blood-Brain Barrier | 1 | 2010 | 63 |
Why?
| Insulin-Like Growth Factor I | 1 | 2010 | 64 |
Why?
| Protein Kinases | 4 | 1988 | 64 |
Why?
| Literature | 1 | 2008 | 6 |
Why?
| Bibliometrics | 1 | 2008 | 6 |
Why?
| Peer Review, Research | 1 | 2008 | 14 |
Why?
| Physician's Role | 1 | 2010 | 92 |
Why?
| Evidence-Based Medicine | 1 | 2009 | 125 |
Why?
| Ion Channels | 4 | 1987 | 61 |
Why?
| Epilepsy, Generalized | 1 | 2005 | 6 |
Why?
| Cyclic AMP | 7 | 1974 | 89 |
Why?
| Brain Chemistry | 1 | 2005 | 60 |
Why?
| Virulence Factors, Bordetella | 9 | 1988 | 22 |
Why?
| Clinical Trials as Topic | 1 | 2009 | 251 |
Why?
| Antineoplastic Agents | 1 | 2010 | 190 |
Why?
| Pertussis Toxin | 8 | 1988 | 25 |
Why?
| Bone Diseases, Metabolic | 1 | 2004 | 17 |
Why?
| Receptors, Opioid, mu | 3 | 1987 | 15 |
Why?
| Convulsants | 4 | 1997 | 10 |
Why?
| Bone Density | 1 | 2004 | 62 |
Why?
| Epilepsy, Temporal Lobe | 1 | 2003 | 17 |
Why?
| Genetic Predisposition to Disease | 1 | 2005 | 131 |
Why?
| Electroencephalography | 2 | 1977 | 88 |
Why?
| Dynorphins | 3 | 1987 | 7 |
Why?
| Cells, Cultured | 16 | 1986 | 447 |
Why?
| Vagus Nerve | 3 | 1990 | 25 |
Why?
| Animals | 37 | 1976 | 1031 |
Why?
| GTP-Binding Proteins | 5 | 1990 | 47 |
Why?
| Receptors, N-Methyl-D-Aspartate | 3 | 2002 | 38 |
Why?
| Analgesics, Opioid | 1 | 2000 | 37 |
Why?
| Membrane Potentials | 11 | 1986 | 99 |
Why?
| Drugs, Generic | 2 | 2008 | 6 |
Why?
| Mice | 18 | 1976 | 623 |
Why?
| Mitosis | 3 | 2002 | 68 |
Why?
| Barbiturates | 2 | 1986 | 12 |
Why?
| Rats | 17 | 1976 | 530 |
Why?
| Brain | 7 | 1976 | 305 |
Why?
| 4-Butyrolactone | 1 | 1997 | 3 |
Why?
| Humans | 20 | 1974 | 1856 |
Why?
| Protein Kinase C | 2 | 1988 | 93 |
Why?
| Bromodeoxyuridine | 4 | 2002 | 47 |
Why?
| Flurothyl | 3 | 2002 | 3 |
Why?
| beta-Endorphin | 1 | 1994 | 12 |
Why?
| Pituitary Neoplasms | 1 | 1994 | 25 |
Why?
| gamma-Aminobutyric Acid | 2 | 1986 | 58 |
Why?
| Pentobarbital | 3 | 1986 | 16 |
Why?
| Guanosine Triphosphate | 3 | 1990 | 22 |
Why?
| Cyclic GMP | 4 | 1979 | 30 |
Why?
| Epilepsia Partialis Continua | 1 | 2003 | 1 |
Why?
| Spasms, Infantile | 1 | 2003 | 5 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 1994 | 62 |
Why?
| Encephalitis | 1 | 2003 | 29 |
Why?
| Autoantibodies | 1 | 2003 | 64 |
Why?
| Evoked Potentials | 6 | 1977 | 44 |
Why?
| Nifedipine | 2 | 1988 | 23 |
Why?
| History, 20th Century | 2 | 1992 | 111 |
Why?
| Phorbol 12,13-Dibutyrate | 2 | 1988 | 11 |
Why?
| Adenosine Triphosphate | 4 | 1974 | 121 |
Why?
| Patch-Clamp Techniques | 4 | 1997 | 47 |
Why?
| Mitochondria | 2 | 2002 | 100 |
Why?
| Rats, Sprague-Dawley | 5 | 1997 | 257 |
Why?
| Corpus Striatum | 3 | 1980 | 48 |
Why?
| Neurogenesis | 1 | 2010 | 18 |
Why?
| Mice, Inbred C57BL | 4 | 2002 | 318 |
Why?
| Weight Loss | 1 | 2010 | 51 |
Why?
| Fluorouracil | 1 | 2010 | 49 |
Why?
| Paclitaxel | 1 | 2010 | 37 |
Why?
| Glycerides | 1 | 1989 | 11 |
Why?
| Diglycerides | 1 | 1989 | 12 |
Why?
| Doxorubicin | 1 | 2010 | 60 |
Why?
| 2-Chloroadenosine | 1 | 1989 | 2 |
Why?
| Muscle Relaxants, Central | 1 | 1989 | 3 |
Why?
| Cyclophosphamide | 1 | 2010 | 82 |
Why?
| Publishing | 1 | 2010 | 30 |
Why?
| Nervous System Diseases | 1 | 2010 | 78 |
Why?
| Perception | 1 | 2008 | 49 |
Why?
| Delirium, Dementia, Amnestic, Cognitive Disorders | 1 | 1988 | 15 |
Why?
| Intracranial Arteriovenous Malformations | 1 | 1988 | 14 |
Why?
| Electrodes | 2 | 1989 | 24 |
Why?
| omega-Conotoxin GVIA | 2 | 1994 | 4 |
Why?
| Excitatory Amino Acids | 1 | 2007 | 5 |
Why?
| Frontal Lobe | 1 | 1988 | 33 |
Why?
| Neuropeptide Y | 3 | 1990 | 8 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2007 | 21 |
Why?
| Bipolar Disorder | 1 | 1988 | 35 |
Why?
| Norepinephrine | 3 | 1974 | 68 |
Why?
| Phenotype | 3 | 2002 | 303 |
Why?
| Muscular Dystrophies | 1 | 2008 | 28 |
Why?
| Hippocampus | 3 | 1980 | 83 |
Why?
| Glutamic Acid | 1 | 2007 | 66 |
Why?
| Predictive Value of Tests | 2 | 2003 | 321 |
Why?
| Research Design | 1 | 2009 | 169 |
Why?
| Biomedical Research | 1 | 2008 | 87 |
Why?
| Physicians | 1 | 2008 | 104 |
Why?
| Cell Proliferation | 1 | 2010 | 227 |
Why?
| Calcium Channel Blockers | 3 | 1997 | 48 |
Why?
| Carbolines | 1 | 1986 | 3 |
Why?
| Receptors, GABA-A | 1 | 1986 | 14 |
Why?
| Anti-Anxiety Agents | 1 | 1986 | 16 |
Why?
| Receptors, Neurotransmitter | 1 | 2005 | 7 |
Why?
| Gene Therapy | 1 | 2008 | 89 |
Why?
| Dose-Response Relationship, Drug | 6 | 1980 | 431 |
Why?
| Electrophysiology | 4 | 1987 | 101 |
Why?
| Cluster Analysis | 1 | 2005 | 66 |
Why?
| Epilepsies, Partial | 1 | 2005 | 11 |
Why?
| Calcium Signaling | 1 | 2007 | 52 |
Why?
| Reactive Oxygen Species | 1 | 2007 | 112 |
Why?
| 8-Bromo Cyclic Adenosine Monophosphate | 3 | 1988 | 16 |
Why?
| Rickets | 1 | 2004 | 6 |
Why?
| Osteomalacia | 1 | 2004 | 5 |
Why?
| Kinetics | 5 | 1974 | 349 |
Why?
| Spinal Cord | 1 | 1986 | 94 |
Why?
| Fractures, Spontaneous | 1 | 2004 | 12 |
Why?
| Hip Fractures | 1 | 2004 | 19 |
Why?
| Genotype | 1 | 2005 | 175 |
Why?
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 2 | 1999 | 7 |
Why?
| Osteoporosis | 1 | 2004 | 47 |
Why?
| Female | 10 | 1979 | 1643 |
Why?
| Aminophylline | 2 | 1979 | 3 |
Why?
| Reserpine | 2 | 1979 | 8 |
Why?
| Tomography, Emission-Computed | 1 | 2003 | 25 |
Why?
| Male | 12 | 1977 | 1553 |
Why?
| Tomography, Emission-Computed, Single-Photon | 1 | 2003 | 33 |
Why?
| N-Methylaspartate | 2 | 1998 | 18 |
Why?
| Kindling, Neurologic | 1 | 2002 | 6 |
Why?
| Sex Factors | 1 | 2004 | 284 |
Why?
| Brain Mapping | 1 | 2003 | 61 |
Why?
| Electric Conductivity | 3 | 1988 | 42 |
Why?
| Stem Cells | 2 | 2002 | 107 |
Why?
| Heterotrimeric GTP-Binding Proteins | 1 | 2001 | 14 |
Why?
| Receptors, GABA-B | 1 | 2000 | 2 |
Why?
| Adult | 6 | 1984 | 1317 |
Why?
| Action Potentials | 3 | 1989 | 77 |
Why?
| Drug Tolerance | 1 | 2000 | 26 |
Why?
| Age Factors | 1 | 2004 | 480 |
Why?
| Calcium Channels, N-Type | 1 | 2000 | 4 |
Why?
| Child | 2 | 2003 | 749 |
Why?
| Glycogen | 1 | 1980 | 17 |
Why?
| Hypoxia, Brain | 1 | 1980 | 15 |
Why?
| Propranolol | 2 | 1974 | 34 |
Why?
| Adenylate Cyclase Toxin | 2 | 1989 | 4 |
Why?
| Quality of Life | 1 | 2004 | 188 |
Why?
| Up-Regulation | 1 | 2002 | 183 |
Why?
| Astrocytoma | 2 | 1974 | 26 |
Why?
| Reproducibility of Results | 1 | 2003 | 391 |
Why?
| Enkephalins | 1 | 1999 | 14 |
Why?
| Phorbol Esters | 2 | 1988 | 12 |
Why?
| Morphine | 1 | 1999 | 38 |
Why?
| Mutation | 1 | 2005 | 340 |
Why?
| Ion Channel Gating | 1 | 2000 | 42 |
Why?
| Type C Phospholipases | 1 | 1999 | 34 |
Why?
| Therapeutic Equivalency | 2 | 2008 | 9 |
Why?
| Forskolin | 2 | 1988 | 19 |
Why?
| Aged | 4 | 1977 | 988 |
Why?
| Homeostasis | 2 | 1989 | 99 |
Why?
| Propionic Acids | 1 | 1998 | 15 |
Why?
| Neurotoxins | 1 | 1998 | 33 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 1999 | 104 |
Why?
| Middle Aged | 4 | 1986 | 1161 |
Why?
| Ethosuximide | 1 | 1997 | 1 |
Why?
| Receptors, Opioid, kappa | 3 | 1987 | 7 |
Why?
| Pentylenetetrazole | 3 | 1979 | 9 |
Why?
| Isoproterenol | 1 | 1977 | 47 |
Why?
| Peptides | 2 | 1994 | 154 |
Why?
| Carbachol | 1 | 1977 | 30 |
Why?
| Phenobarbital | 2 | 1986 | 19 |
Why?
| Calcitonin Gene-Related Peptide | 2 | 1992 | 10 |
Why?
| Magnetic Resonance Imaging | 1 | 2003 | 294 |
Why?
| Isoenzymes | 1 | 1999 | 144 |
Why?
| Enzyme Activation | 2 | 1989 | 177 |
Why?
| Pain | 1 | 1999 | 191 |
Why?
| Behavior, Animal | 3 | 1980 | 77 |
Why?
| Adolescent | 3 | 1988 | 891 |
Why?
| Animals, Newborn | 1 | 1997 | 175 |
Why?
| Allosteric Site | 1 | 1994 | 6 |
Why?
| Time Factors | 4 | 1974 | 896 |
Why?
| Electric Stimulation | 2 | 1990 | 101 |
Why?
| Adrenocorticotropic Hormone | 1 | 1994 | 31 |
Why?
| Receptors, Opioid, delta | 2 | 1987 | 7 |
Why?
| Acetylcholine | 2 | 1990 | 49 |
Why?
| Serologic Tests | 1 | 2003 | 24 |
Why?
| Receptors, Neuropeptide Y | 1 | 1993 | 1 |
Why?
| Syndrome | 1 | 2003 | 142 |
Why?
| Protein Subunits | 1 | 2003 | 44 |
Why?
| Protein Processing, Post-Translational | 1 | 1994 | 78 |
Why?
| Epitopes | 1 | 2003 | 86 |
Why?
| Synaptic Transmission | 1 | 1993 | 58 |
Why?
| History, 17th Century | 1 | 1992 | 5 |
Why?
| History, Medieval | 1 | 1992 | 10 |
Why?
| History, Ancient | 1 | 1992 | 13 |
Why?
| History, 18th Century | 1 | 1992 | 15 |
Why?
| Tacrine | 1 | 1991 | 1 |
Why?
| History, 19th Century | 1 | 1992 | 40 |
Why?
| Reference Values | 1 | 2003 | 278 |
Why?
| Pregnancy | 2 | 1987 | 455 |
Why?
| Binding Sites | 1 | 1994 | 213 |
Why?
| Cell Count | 2 | 2002 | 163 |
Why?
| Tumor Cells, Cultured | 1 | 1994 | 233 |
Why?
| Disease Progression | 1 | 2003 | 244 |
Why?
| Vascular Resistance | 1 | 1991 | 51 |
Why?
| Chronic Disease | 1 | 2003 | 267 |
Why?
| Phosphorylation | 1 | 1994 | 224 |
Why?
| Islets of Langerhans | 1 | 1991 | 26 |
Why?
| Thionucleotides | 1 | 1990 | 15 |
Why?
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1990 | 8 |
Why?
| Blotting, Western | 2 | 1997 | 275 |
Why?
| Naloxone | 1 | 1990 | 22 |
Why?
| Pancreas | 1 | 1991 | 46 |
Why?
| Potassium | 2 | 1987 | 98 |
Why?
| Macromolecular Substances | 1 | 1990 | 92 |
Why?
| Valproic Acid | 1 | 1990 | 26 |
Why?
| Protein Kinase Inhibitors | 1 | 1990 | 59 |
Why?
| Drug Interactions | 2 | 1977 | 111 |
Why?
| Depression, Chemical | 1 | 1989 | 40 |
Why?
| Cholera Toxin | 1 | 1989 | 17 |
Why?
| Barium | 1 | 1988 | 16 |
Why?
| Interdisciplinary Communication | 1 | 2008 | 26 |
Why?
| Carbamazepine | 1 | 1988 | 10 |
Why?
| Molecular Biology | 1 | 2008 | 38 |
Why?
| Lithium | 1 | 1988 | 28 |
Why?
| Disease Models, Animal | 2 | 2002 | 349 |
Why?
| Comet Assay | 1 | 2007 | 6 |
Why?
| Insulin | 1 | 1991 | 129 |
Why?
| Infant | 1 | 2003 | 464 |
Why?
| Neostriatum | 1 | 2007 | 20 |
Why?
| Indicators and Reagents | 1 | 2007 | 79 |
Why?
| Lysosomes | 1 | 2007 | 38 |
Why?
| Health Surveys | 1 | 2008 | 103 |
Why?
| Receptors, Opioid | 1 | 1987 | 16 |
Why?
| Child, Preschool | 1 | 2003 | 554 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 167 |
Why?
| Data Interpretation, Statistical | 1 | 2007 | 109 |
Why?
| Myelitis | 1 | 1986 | 3 |
Why?
| Hepatovirus | 1 | 1986 | 2 |
Why?
| Clonazepam | 1 | 1986 | 1 |
Why?
| Nitrazepam | 1 | 1986 | 1 |
Why?
| Picrotoxin | 1 | 1986 | 7 |
Why?
| Bicuculline | 1 | 1986 | 12 |
Why?
| Immunohistochemistry | 2 | 1997 | 355 |
Why?
| Diazepam | 1 | 1986 | 17 |
Why?
| Cytomegalovirus | 1 | 1986 | 42 |
Why?
| Hydrogen-Ion Concentration | 1 | 2007 | 176 |
Why?
| Adenosine | 2 | 1974 | 57 |
Why?
| Dizziness | 1 | 2005 | 10 |
Why?
| Ataxia | 1 | 2005 | 17 |
Why?
| Signal Transduction | 1 | 1994 | 313 |
Why?
| Models, Biological | 1 | 1990 | 410 |
Why?
| Meningeal Neoplasms | 1 | 1984 | 30 |
Why?
| Drug Therapy, Combination | 1 | 2005 | 189 |
Why?
| Drug Administration Schedule | 1 | 2005 | 191 |
Why?
| Glioma | 1 | 1984 | 51 |
Why?
| Antimetabolites | 1 | 2002 | 21 |
Why?
| Gamma Rays | 1 | 2003 | 38 |
Why?
| Excitatory Amino Acid Agonists | 1 | 2002 | 27 |
Why?
| Double-Blind Method | 1 | 2005 | 274 |
Why?
| Cyclosporine | 1 | 2002 | 45 |
Why?
| Coliphages | 1 | 2001 | 11 |
Why?
| Cell Death | 1 | 2002 | 94 |
Why?
| Microscopy, Confocal | 1 | 2002 | 105 |
Why?
| Phosphocreatine | 1 | 1980 | 11 |
Why?
| Hydroxydopamines | 1 | 1980 | 13 |
Why?
| Cerebellum | 1 | 1980 | 59 |
Why?
| Neuroglia | 1 | 2002 | 49 |
Why?
| United States | 1 | 2008 | 604 |
Why?
| Phentolamine | 2 | 1974 | 10 |
Why?
| Sequence Homology, Amino Acid | 1 | 2001 | 156 |
Why?
| Cell Division | 1 | 2003 | 273 |
Why?
| Prospective Studies | 1 | 2005 | 545 |
Why?
| Phospholipase C beta | 1 | 1999 | 10 |
Why?
| Energy Metabolism | 1 | 1980 | 80 |
Why?
| Potassium Channels | 1 | 2001 | 33 |
Why?
| Nitro Compounds | 1 | 1998 | 9 |
Why?
| Cerebral Cortex | 1 | 1980 | 108 |
Why?
| Drug Synergism | 1 | 1998 | 104 |
Why?
| Blindness | 1 | 1977 | 22 |
Why?
| Aged, 80 and over | 1 | 2005 | 599 |
Why?
| Magnesium | 1 | 1998 | 69 |
Why?
| Protein Binding | 1 | 2001 | 256 |
Why?
| Cytosol | 1 | 1998 | 79 |
Why?
| Thiourea | 1 | 1977 | 4 |
Why?
| Parasympatholytics | 1 | 1977 | 10 |
Why?
| Prostaglandins E | 1 | 1977 | 22 |
Why?
| Naltrexone | 1 | 1997 | 8 |
Why?
| Embryo, Mammalian | 1 | 1998 | 99 |
Why?
| Cell Membrane | 1 | 1999 | 170 |
Why?
| Narcotic Antagonists | 1 | 1997 | 13 |
Why?
| Amino Acid Sequence | 1 | 2001 | 319 |
Why?
| Guanylate Cyclase | 1 | 1976 | 10 |
Why?
| Ascorbic Acid | 1 | 1977 | 37 |
Why?
| Adenine Nucleotides | 1 | 1976 | 15 |
Why?
| Treatment Outcome | 1 | 2005 | 661 |
Why?
| Guanine Nucleotides | 1 | 1976 | 13 |
Why?
| Visual Cortex | 1 | 1977 | 26 |
Why?
| Lidocaine | 1 | 1977 | 49 |
Why?
| Cell Survival | 1 | 1998 | 229 |
Why?
| Mice, Knockout | 1 | 1999 | 265 |
Why?
| Analysis of Variance | 1 | 1998 | 339 |
Why?
| Molecular Sequence Data | 1 | 2001 | 404 |
Why?
| Adenosine Monophosphate | 1 | 1974 | 14 |
Why?
| Cell Line | 2 | 1974 | 375 |
Why?
| Adenosine Diphosphate | 1 | 1974 | 30 |
Why?
| Gene Expression Regulation | 1 | 1999 | 277 |
Why?
| Receptors, Calcitonin | 1 | 1992 | 6 |
Why?
| Differential Threshold | 1 | 1991 | 8 |
Why?
| Cholinesterase Inhibitors | 1 | 1991 | 11 |
Why?
| Peptide Fragments | 1 | 1993 | 144 |
Why?
| Perfusion | 1 | 1991 | 73 |
Why?
| Receptors, Cell Surface | 1 | 1992 | 115 |
Why?
| Rats, Inbred Strains | 1 | 1991 | 170 |
Why?
| Biomechanics | 1 | 1990 | 79 |
Why?
| Cytological Techniques | 1 | 1984 | 18 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 1984 | 37 |
Why?
| Parietal Lobe | 1 | 1977 | 17 |
Why?
| Optic Nerve | 1 | 1977 | 27 |
Why?
| Cerebral Infarction | 1 | 1977 | 36 |
Why?
| Visual Pathways | 1 | 1977 | 25 |
Why?
| Dogs | 1 | 1977 | 159 |
Why?
| Neural Pathways | 1 | 1977 | 48 |
Why?
| Photic Stimulation | 1 | 1977 | 58 |
Why?
| Guinea Pigs | 1 | 1976 | 76 |
Why?
| Solubility | 1 | 1976 | 75 |
Why?
| Manganese | 1 | 1976 | 33 |
Why?
| Chromatography, Paper | 1 | 1974 | 17 |
Why?
| Papaverine | 1 | 1974 | 5 |
Why?
| Xanthines | 1 | 1974 | 10 |
Why?
| Theophylline | 1 | 1974 | 19 |
Why?
| Chromatography, Ion Exchange | 1 | 1974 | 36 |
Why?
| Carbon Radioisotopes | 1 | 1974 | 43 |
Why?
| Tritium | 1 | 1974 | 65 |
Why?
| Receptors, Drug | 1 | 1974 | 16 |
Why?
| Phosphoric Diester Hydrolases | 1 | 1974 | 29 |
Why?
| Adenine | 1 | 1974 | 26 |
Why?
| Myocardium | 1 | 1976 | 119 |
Why?
| Clone Cells | 1 | 1974 | 92 |
Why?
| Biological Transport | 1 | 1974 | 129 |
Why?
| Lung | 1 | 1976 | 232 |
Why?
|
|
Gross's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
